148 related articles for article (PubMed ID: 32198408)
1. Enhanced expression of Cyclin D1 and C-myc, a prognostic factor and possible mechanism for recurrence of papillary thyroid carcinoma.
Sanjari M; Kordestani Z; Safavi M; Mashrouteh M; FekriSoofiAbadi M; Ghaseminejad Tafreshi A
Sci Rep; 2020 Mar; 10(1):5100. PubMed ID: 32198408
[TBL] [Abstract][Full Text] [Related]
2. ENHANCED BETA-CATENIN EXPRESSION IS ASSOCIATED WITH RECURRENCE OF PAPILLARY THYROID CARCINOMA.
Kordestani Z; Sanjari M; Safavi M; Mashrouteh M; Asadikaram G; Abadi MFS; Mirzazadeh A
Endocr Pract; 2018 May; 24(5):411-418. PubMed ID: 29498921
[TBL] [Abstract][Full Text] [Related]
3. Expression and significance of Wnt signaling components and their target genes in breast carcinoma.
He Y; Liu Z; Qiao C; Xu M; Yu J; Li G
Mol Med Rep; 2014 Jan; 9(1):137-43. PubMed ID: 24190141
[TBL] [Abstract][Full Text] [Related]
4. Elevated protein expression of cyclin D1 and Fra-1 but decreased expression of c-Myc in human colorectal adenocarcinomas overexpressing beta-catenin.
Wang HL; Wang J; Xiao SY; Haydon R; Stoiber D; He TC; Bissonnette M; Hart J
Int J Cancer; 2002 Oct; 101(4):301-10. PubMed ID: 12209953
[TBL] [Abstract][Full Text] [Related]
5. MYC promotes the development of papillary thyroid carcinoma by inhibiting the expression of lncRNA PAX8‑AS1:28.
Zhang Y; Li F; Chen J
Oncol Rep; 2019 Apr; 41(4):2511-2517. PubMed ID: 30720110
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of β-catenin, c-myc, and cyclin D1 expressions in patients with esophageal squamous cell carcinoma.
Wang W; Xue L; Wang P
Med Oncol; 2011 Mar; 28(1):163-9. PubMed ID: 20143187
[TBL] [Abstract][Full Text] [Related]
7. ANXA1 (Annexin A1) regulated by MYC (MYC proto-oncogene) promotes the growth of papillary thyroid carcinoma.
Ying X; Chen L; Xie J; Hu Y; Wu Q; Cao L; Yu H
Bioengineered; 2021 Dec; 12(2):9251-9265. PubMed ID: 34723715
[TBL] [Abstract][Full Text] [Related]
8. [Expression and significance of APC, beta-catenin, C-myc, and Cyclin D1 proteins in colorectal carcinoma].
Dai WB; Ren ZP; Chen WL; DU J; Shi Z; Tang DY
Ai Zheng; 2007 Sep; 26(9):963-6. PubMed ID: 17927853
[TBL] [Abstract][Full Text] [Related]
9. Role of Lin28A/let-7a/c-Myc Pathway in Growth and Malignant Behavior of Papillary Thyroid Carcinoma.
Huang J; Lin H; Zhong M; Huang J; Sun S; Lin L; Chen Y
Med Sci Monit; 2018 Dec; 24():8899-8909. PubMed ID: 30531691
[TBL] [Abstract][Full Text] [Related]
10. Beta-catenin mutations correlate with over expression of C-myc and cyclin D1 Genes in bladder cancer.
Shiina H; Igawa M; Shigeno K; Terashima M; Deguchi M; Yamanaka M; Ribeiro-Filho L; Kane CJ; Dahiya R
J Urol; 2002 Nov; 168(5):2220-6. PubMed ID: 12394763
[TBL] [Abstract][Full Text] [Related]
11. The Wnt/β-catenin pathway drives increased cyclin D1 levels in lymph node metastasis in papillary thyroid cancer.
Zhang J; Gill AJ; Issacs JD; Atmore B; Johns A; Delbridge LW; Lai R; McMullen TP
Hum Pathol; 2012 Jul; 43(7):1044-50. PubMed ID: 22204713
[TBL] [Abstract][Full Text] [Related]
12. Low-grade slightly elevated and polypoid colorectal adenomas display differential β-catenin-TCF/LEF activity, c-Myc, and cyclin D1 expression.
Yang TW; Gao YH; Ma SY; Wu Q; Li ZF
World J Gastroenterol; 2017 May; 23(17):3066-3076. PubMed ID: 28533663
[TBL] [Abstract][Full Text] [Related]
13. Cyclin D1 overexpression in thyroid tumours from a radio-contaminated area and its correlation with Pin1 and aberrant beta-catenin expression.
Nakashima M; Meirmanov S; Naruke Y; Kondo H; Saenko V; Rogounovitch T; Shimizu-Yoshida Y; Takamura N; Namba H; Ito M; Abrosimov A; Lushnikov E; Roumiantsev P; Tsyb A; Yamashita S; Sekine I
J Pathol; 2004 Apr; 202(4):446-55. PubMed ID: 15095272
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of cyclin D1, β-catenin, and MTA1 in patients with invasive ductal carcinoma of the breast.
Cheng CW; Liu YF; Yu JC; Wang HW; Ding SL; Hsiung CN; Hsu HM; Shieh JC; Wu PE; Shen CY
Ann Surg Oncol; 2012 Dec; 19(13):4129-39. PubMed ID: 22864797
[TBL] [Abstract][Full Text] [Related]
15. Association of nuclear localization of SHP2 and YAP1 with unfavorable prognosis in non-small cell lung cancer.
Chen MJ; Wang YC; Wu DW; Chen CY; Lee H
Pathol Res Pract; 2019 Apr; 215(4):801-806. PubMed ID: 30685130
[TBL] [Abstract][Full Text] [Related]
16. [Relationship between the expression of beta-cat, cyclin D1 and c-myc and the occurance and biological behavior of pancreatic cancer].
Li YJ; Ji XR
Zhonghua Bing Li Xue Za Zhi; 2003 Jun; 32(3):238-41. PubMed ID: 12882690
[TBL] [Abstract][Full Text] [Related]
17. A survival-stratification model of human colorectal carcinomas with beta-catenin and p27kip1.
Cheah PY; Choo PH; Yao J; Eu KW; Seow-Choen F
Cancer; 2002 Dec; 95(12):2479-86. PubMed ID: 12467060
[TBL] [Abstract][Full Text] [Related]
18. p53, Cyclin-D1, β-catenin, APC and c-myc in Tumor Tissue from Colorectal and Gastric Cancer Patients with Suspected Lynch Syndrome by the Bethesda Criteria.
Marcolino TF; Pimenta CAM; Artigiani Neto R; Castelo P; Silva MS; Forones NM; Oshima CTF
Asian Pac J Cancer Prev; 2020 Feb; 21(2):343-348. PubMed ID: 32102509
[TBL] [Abstract][Full Text] [Related]
19. The expression of S100P increases and promotes cellular proliferation by increasing nuclear translocation of β-catenin in endometrial cancer.
Guo L; Chen S; Jiang H; Huang J; Jin W; Yao S
Int J Clin Exp Pathol; 2014; 7(5):2102-12. PubMed ID: 24966918
[TBL] [Abstract][Full Text] [Related]
20. Expression of potential beta-catenin targets, cyclin D1, c-Jun, c-Myc, E-cadherin, and EGFR in chemically induced hepatocellular neoplasms from B6C3F1 mice.
Anna CH; Iida M; Sills RC; Devereux TR
Toxicol Appl Pharmacol; 2003 Jul; 190(2):135-45. PubMed ID: 12878043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]